Kito S, Koga H, Kodama M, Habu M, Kokuryo S, Oda M, Matsuo K, Nishino T, Matsumoto-Takeda S, Uehara M, Yoshiga D, Tanaka T, Nishimura S, Miyamoto I, Sasaguri M, Tominaga K, Yoshioka I, Morimoto Y. Alterations in 18F-FDG accumulation into neck-related muscles after neck dissection for patients with oral cancers. Med Oral Patol Oral Cir Bucal. 2016 May 1;21 (3):e341-8. 

 

 

doi:10.4317/medoral.21018

http://dx.doi.org/doi:10.4317/medoral.21018

 

 

1. Isles MG, McConkey C, Mehanna HM. A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clin Otolaryngol. 2008;33:210-22.
http://dx.doi.org/10.1111/j.1749-4486.2008.01688.x

 

2. Fischbein NJ, AAssar OS, Caputo GR, Kaplan MJ, Singer MI, Price DC, et al. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. AJNR Am J Neuroradiol. 1998;19:1189-96.

 

3. Seitz O, Chambron-Pinho N, Middendorp M, Sader R, Mack M, Vogl TJ, et al. 18F-Fluorodeoxyglucose-PET/CT to evaluate tumor, nodal disease, and gross tumor volume of oropharyngeal and oral cavity cancer: comparison with MR imaging and-validation with surgical specimen. Neuroradiology. 2009;51:677-86.
http://dx.doi.org/10.1007/s00234-009-0586-8

 

4. Roh JL, Yeo NK, Kim JS, Lee JH, Cho KJ, Choi SH, et al. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Oral Oncol. 2007;43:887-93.
http://dx.doi.org/10.1016/j.oraloncology.2006.10.011

 

5. Ng SH, Yen TC, Chang JT, Chan SC, Ko SF, Wang HM, et al. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. J Clin Oncol. 2006;24:4371-6.
http://dx.doi.org/10.1200/JCO.2006.05.7349

 

6. Pasha MA, Marcus C, Fakhry C, Kang H, Kiess AP, Subramaniam RM. FDG PET/CT for management and assessing outcomes of squamous cell cancer of the oral cavity. Am J Roentgenol. 2015;205:150-61.
http://dx.doi.org/10.2214/AJR.14.13830

 

7. Kito S, Koga H, Kodama M, Yamamoto N, Kokuryo S, Habu M, et al. Reflection of 18F-FDG accumulation in the evaluation of the extent of periapical or periodontal inflammation. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114:e62-9.
http://dx.doi.org/10.1016/j.oooo.2012.05.027

 

8. McGarvey AC, Osmotherly PG, Hoffman GR, Chiarelli PE. Scapular muscle exercises following neck dissection surgery for head and neck cancer: a comparative electromyographic study. Phys Ther. 2013;93:786-97.
http://dx.doi.org/10.2522/ptj.20120385

 

9. McGarvey AC, Osmotherly PG, Hoffman GR, Chiarelli PE. Impact of neck dissection on scapular muscle function: a case-controlled electromyographic study. Arch Phys Med Rehabil. 2013;94:113-9.
http://dx.doi.org/10.1016/j.apmr.2012.07.017

 

10. McGarvey AC, Chiarelli PE, Osmotherly PG, Hoffman GR. Physiotherapy for accessory nerve shoulder dysfunction following neck dissection surgery: a literature review. Head Neck. 2011;33:274-80.
http://dx.doi.org/10.1002/hed.21366

 

11. Andreadis D, Stylianou F, Link-Tsatsouli I, Markopoulos A. Bilateral masseter and internal pterygoid muscle hypertrophy: a diagnostic challenge. Med Princ Pract. 2014;23:286-8.
http://dx.doi.org/10.1159/000354099

 

12. Ariji Y, Fuwa N, Kodaira T, Tachibana H, Nakamura T, Satoh Y, et al. False-positive positron emission tomography appearance with 18F-fluorodeoxyglucose after definitive radiotherapy for cancer of the mobile tongue. Br J Radiol. 2009;82:e3-7.
http://dx.doi.org/10.1259/bjr/96087474

 

13. Kito S, Koga H, Kodama M, Habu M, Kokuryo S, Yamamoto N, et al. Variety and complexity of fluorine-18-labelled fluoro-2-deoxy-D-glucose accumulations in the oral cavity of patients with oral cancers. Dentomaxillofac Radiol. 2013;42:20130014.
http://dx.doi.org/10.1259/dmfr.20130014

 

14. Miyashita G, Higuchi T, Oriuchi N, Arisaka Y, Hanaoka H, Tominaga H, et al. 18F-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: comparative study with 18F-FDG PET and immunohistochemistry. Ann Nucl Med. 2010;24:579-84.
http://dx.doi.org/10.1007/s12149-010-0398-2

 

15. Miyawaki A, Ikeda R, Hijioka H, Ishida T, Ushiyama M, Nozoe E, et al. SUVmax of FDG-PET correlates with the effects of neoadjuvant chemoradiotherapy for oral squamous cell carcinoma. Oncol Rep. 2010;23:1205-12.
http://dx.doi.org/10.3892/or_00000751

 

16. Schwartz DL, Ford E, Rajendran J, Yueh B, Coltrera MD, Virgin J, et al. Laramore GE. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2005;61:129-36.
http://dx.doi.org/10.1016/j.ijrobp.2004.03.040